{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:48:08Z","timestamp":1773283688159,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,10]],"date-time":"2018-08-10T00:00:00Z","timestamp":1533859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,8,10]],"date-time":"2018-08-10T00:00:00Z","timestamp":1533859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Obesity, often represented by higher body mass index (BMI), is not yet fully understood as a potential risk factor for poor clinical outcomes of prostate cancer (PCa) after radical prostatectomy (RP). This study aimed to evaluate the relationship between BMI and biochemical recurrence (BCR)-free survival in RP patients. This study retrospectively reviewed a total of 2.997 PCa patients who underwent RP between 2006 and 2017. The patients were stratified into three BMI groups according to the WHO recommendations for Asian men: normal weight (&lt;23\u2009kg\/m<jats:sup>2<\/jats:sup>), overweight (\u226523 to &lt;27.5\u2009kg\/m<jats:sup>2<\/jats:sup>) and obese (\u226527.5\u2009kg\/m<jats:sup>2<\/jats:sup>). Multivariable logistic regression analyses were undertaken to evaluate the factors influencing the BCR rates including BMI. Multivariable Cox regression analyses and Kaplan-Meier analyses were performed to test the association of obesity with BCR-free survival. The final pathologic results showed obese patients had greater positive surgical margin rates (13.9%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), extraprostatic invasion (19.9%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), advanced pathological Gleason score (GS)\u2009\u2265\u20098 (50.8%, <jats:italic>p<\/jats:italic>\u2009=\u20090.017), and lymph node invasion (LNI) (14.5%, <jats:italic>p<\/jats:italic>\u2009=\u20090.021) than overweight and normal weight patients. According to Kaplan-Meier analyses, obese patients, especially with BMI\u2009\u2265\u200927.5, were more likely to have lower BCR-free-survival. Multivariate Cox analysis revealed that diabetes mellitus, LNI status, pT, pathologic GS, extraprostatic invasion, margin positivity and obesity with BMI\u2009\u2265\u200927.5\u2009kg\/m<jats:sup>2<\/jats:sup> were significantly associated with BCR-free survival after RP. Obesity (higher BMI) was significantly associated with BCR after RP. BMI\u2009\u2265\u200927.5\u2009kg\/m<jats:sup>2<\/jats:sup> was an independent predictor of BCR-free survival.<\/jats:p>","DOI":"10.1038\/s41598-018-30473-y","type":"journal-article","created":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T09:36:29Z","timestamp":1533548189000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Impact of Body Mass Index on Oncological Outcomes of Prostate Cancer Patients after Radical Prostatectomy"],"prefix":"10.1038","volume":"8","author":[{"given":"Young Dong","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seok-Soo","family":"Byun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Eun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8344-6774","authenticated-orcid":false,"given":"Sung Kyu","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,10]]},"reference":[{"key":"30473_CR1","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1200\/JCO.2014.58.4680","volume":"32","author":"JA Ligibel","year":"2014","unstructured":"Ligibel, J. A. et al. American Society of Clinical Oncology position statement on obesity and cancer. J Clin Oncol. 32, 68\u201374 (2014).","journal-title":"J Clin Oncol."},{"key":"30473_CR2","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1056\/NEJMoa021423","volume":"348","author":"EE Calle","year":"2003","unstructured":"Calle, E. E., Rodriguez, C., Walker-Thurmond, K. & Thun, M. J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 348, 1625\u201338 (2003).","journal-title":"N Engl J Med."},{"key":"30473_CR3","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1093\/jnci\/djp278","volume":"101","author":"HG Welch","year":"2009","unstructured":"Welch, H. G. & Albertsen, P. C. Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening. 1986\u20132005. J Natl Cancer Inst. 101, 1325\u201329 (2009).","journal-title":"J Natl Cancer Inst."},{"issue":"266","key":"30473_CR4","first-page":"e17","volume":"33","author":"A Lee","year":"2015","unstructured":"Lee, A. & Chia, S. J. Prostate cancer detection: the impact of obesity on Asian men. Urol Oncol. 33(266), e17\u2013e22 (2015).","journal-title":"Urol Oncol."},{"key":"30473_CR5","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/S1470-2045(08)70235-3","volume":"9","author":"J Ma","year":"2008","unstructured":"Ma, J. et al. Prediagnostic body mass index, plasma peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis. Lancet Oncol. 9, 1039\u201347 (2008).","journal-title":"Lancet Oncol."},{"key":"30473_CR6","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1002\/cncr.22534","volume":"109","author":"Z Gong","year":"2007","unstructured":"Gong, Z., Agalliu, I., Lin, D. W., Stanford, J. L. & Kristal, A. R. Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middle-aged men. Cancer. 109, 1192\u2013202 (2007).","journal-title":"Cancer."},{"key":"30473_CR7","doi-asserted-by":"publisher","first-page":"245642","DOI":"10.1155\/2011\/245642","volume":"2011","author":"JM Post","year":"2011","unstructured":"Post, J. M. et al. The metabolic syndrome and biochemical recurrence following radical prostatectomy. Prostate Cancer. 2011, 245642 (2011).","journal-title":"Prostate Cancer."},{"issue":"10","key":"30473_CR8","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1016\/j.ejca.2009.01.031","volume":"45","author":"JR Jaggers","year":"2009","unstructured":"Jaggers, J. R. et al. Metabolic syndrome and risk of cancer mortality in men. Eur J Cancer. 45(10), 1831\u20138 (2009).","journal-title":"Eur J Cancer."},{"key":"30473_CR9","unstructured":"The 2017 NCCN clinical practice guidelines in oncology on prostate cancer. J Natl Compr Canc Netw. 2, 10\u201312 (2017)."},{"key":"30473_CR10","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1158\/1055-9965.EPI-14-0795","volume":"23","author":"AC Vidal","year":"2014","unstructured":"Vidal, A. C. et al. Obesity increases the risk for high-grade prostate cancer: results from the REDUCE study. Cancer Epidemiol Biomarkers Prev. 23, 2936\u201342 (2014).","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"issue":"17","key":"30473_CR11","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.1002\/cncr.29472","volume":"121","author":"LS Wang","year":"2015","unstructured":"Wang, L. S. et al. Impact of obesity on outcomes after definitive dose escalated intensity-modulated radiotherapy for localized prostate cancer. Cancer. 121(17), 3010\u20137 (2015).","journal-title":"Cancer."},{"key":"30473_CR12","first-page":"997","volume":"31","author":"C De Nunzio","year":"2013","unstructured":"De Nunzio, C. et al. Abdominal obesity as risk factor for prostate cancer diagnosis and high grade disease: a prospective multicenter Italian cohort study. UrolOncol. 31, 997\u20131002 (2013).","journal-title":"UrolOncol."},{"issue":"5","key":"30473_CR13","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.urology.2012.10.080","volume":"81","author":"JJ Tomaszewski","year":"2013","unstructured":"Tomaszewski, J. J. et al. Obesity is not associated with aggressive pathologic features or biochemical recurrence after radical prostatectomy. Urology. 81(5), 992\u20136 (2013).","journal-title":"Urology."},{"issue":"1","key":"30473_CR14","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/pcan.2012.32","volume":"16","author":"R Asmar","year":"2013","unstructured":"Asmar, R., Beebe-Dimmer, J. L., Korgavkar, K., Keele, G. R. & Cooney, K. A. Hypertension, obesity and prostate cancer biochemical recurrence after radical prostatectomy. Prostate Cancer Prostatic Dis. 16(1), 62\u20136 (2013).","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"4","key":"30473_CR15","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1158\/1940-6207.CAPR-10-0229","volume":"4","author":"Y Cao","year":"2011","unstructured":"Cao, Y. & Ma, J. Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis. Cancer Prev Res (Phila). 4(4), 486\u2013501 (2011).","journal-title":"Cancer Prev Res (Phila)."},{"issue":"3","key":"30473_CR16","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1200\/JCO.2004.03.132","volume":"22","author":"CL Amling","year":"2004","unstructured":"Amling, C. L. et al. Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy. J Clin Oncol. 22(3), 439\u201345 (2004).","journal-title":"J Clin Oncol."},{"issue":"4","key":"30473_CR17","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1002\/cncr.22443","volume":"109","author":"ME Wright","year":"2007","unstructured":"Wright, M. E. et al. Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality. Cancer. 109(4), 675\u201384 (2007).","journal-title":"Cancer."},{"issue":"5","key":"30473_CR18","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1097\/01.ju.0000177077.53037.72","volume":"174","author":"SJ Freedland","year":"2005","unstructured":"Freedland, S. J. et al. Obesity and capsular incision at the time of open retropubic radical prostatectomy. J Urol. 174(5), 1798\u2013801 (2005).","journal-title":"J Urol."},{"issue":"1","key":"30473_CR19","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.eururo.2007.03.054","volume":"52","author":"T Mistry","year":"2007","unstructured":"Mistry, T., Digby, J. E., Desai, K. M. & Randeva, H. S. Obesity and prostate cancer: a role for adipokines. Eur Urol. 52(1), 46\u201353 (2007).","journal-title":"Eur Urol."},{"key":"30473_CR20","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/j.1464-410X.2008.07534.x","volume":"102","author":"MR Hoda","year":"2008","unstructured":"Hoda, M. R. & Popken, G. Mitogenic and anti-apoptotic actions of adipocyte-derived hormone leptin in prostate cancer cells. BJU Int. 102, 383 (2008).","journal-title":"BJU Int."},{"issue":"5","key":"30473_CR21","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.eururo.2012.11.013","volume":"63","author":"EH Allott","year":"2013","unstructured":"Allott, E. H., Masko, E. M. & Freedland, S. J. Obesity and prostate cancer: weighing the evidence. Eur Urol. 63(5), 800\u20139 (2013).","journal-title":"Eur Urol."},{"issue":"6","key":"30473_CR22","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s10552-015-0554-z","volume":"26","author":"I Agalliu","year":"2015","unstructured":"Agalliu, I. et al. The impact of obesity on prostate cancer recurrence observed after exclusion of diabetics. Cancer Causes Control. 26(6), 821\u201330 (2015).","journal-title":"Cancer Causes Control."},{"issue":"11","key":"30473_CR23","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1038\/ijo.2015.111","volume":"39","author":"K Ohwaki","year":"2015","unstructured":"Ohwaki, K., Endo, F. & Hattori, K. Visceral adipose tissue measured by computed tomography and high-grade prostate cancer after radical prostatectomy. International Journal of Obesity. 39(11), 1659\u201361 (2015).","journal-title":"International Journal of Obesity."},{"issue":"2","key":"30473_CR24","doi-asserted-by":"publisher","first-page":"255","DOI":"10.2337\/dc07-0531","volume":"31","author":"JW Kwon","year":"2008","unstructured":"Kwon, J. W. et al. Effects of age, time period, and birth cohort on the prevalence of diabetes and obesity in Korean men. Diabetes Care. 31(2), 255\u201360 (2008).","journal-title":"Diabetes Care."},{"key":"30473_CR25","first-page":"1438027","volume":"2017","author":"G Ji","year":"2017","unstructured":"Ji, G. et al. Are the pathological characteristics of prostate cancer more aggressive or more indolent depending upon the patient age? Biomed research international. 2017, 1438027 (2017).","journal-title":"Biomed research international."},{"key":"30473_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2572-y","volume":"16","author":"K Yamoah","year":"2016","unstructured":"Yamoah, K. et al. The impact of body mass index on treatment outcomes for patients with low-intermediate risk prostate cancer. BMC Cancer. 16, 557 (2016).","journal-title":"BMC Cancer."},{"issue":"4","key":"30473_CR27","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.juro.2014.04.086","volume":"192","author":"HJ Chalfin","year":"2014","unstructured":"Chalfin, H. J. et al. Obesity and long-term survival after radical prostatectomy. J Urol. 192(4), 1100\u20134 (2014).","journal-title":"J Urol."},{"issue":"1","key":"30473_CR28","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0022-5347(06)00589-1","volume":"176","author":"CG Bacon","year":"2006","unstructured":"Bacon, C. G. et al. A prospective study of risk factors for erectile dysfunction. J Urol. 176(1), 217\u201321 (2006).","journal-title":"J Urol."},{"issue":"2","key":"30473_CR29","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.urology.2008.08.493","volume":"73","author":"AL Wiltz","year":"2009","unstructured":"Wiltz, A. L. et al. Robotic radical prostatectomy in overweight and obese patients: oncological and validated-functional outcomes. Urology. 73(2), 316\u201322 (2009).","journal-title":"Urology."},{"key":"30473_CR30","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1046\/j.1532-5415.2001.49088.x","volume":"49","author":"MH Blanker","year":"2001","unstructured":"Blanker, M. H. et al. Correlates for erectile and ejaculatory dysfunction in older Dutch men: a community based study. J Am Geriatr Soc. 49, 436 (2001).","journal-title":"J Am Geriatr Soc."},{"key":"30473_CR31","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.urology.2004.10.061","volume":"65","author":"TE Ahlering","year":"2005","unstructured":"Ahlering, T. E., Eichel, L., Edwards, R. & Skarecky, D. W. Impact of obesity on clinical outcomes in robotic prostatectomy. Urology. 65, 740\u20134 (2005).","journal-title":"Urology."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-30473-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-30473-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-30473-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T08:27:19Z","timestamp":1671611239000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-30473-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,10]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["30473"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-30473-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,10]]},"assertion":[{"value":"1 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"11962"}}